Heart Failure, Unspecified Clinical Trial
Study Protocol/ Registry of MultiPoint™ Pacing in Brazil
This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 200 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 10 centers.
Any patient receiving a market-approved SJM Quadra Assura MP (CRT-D) or newer model
quadripolar device with MPP capability and who meets the inclusion criteria and none of the
exclusion criteria is eligible for enrollment in the study.
Patients will be followed for 12 months after implant. Data will be collected after device implant (up to 30 days after successful implant), at 3, 6 and 12 months post-implant and during unscheduled visits. ;
|Study type||Observational [Patient Registry]|
|Source||Abbott Medical Devices|
|Start date||May 18, 2017|
|Completion date||February 8, 2019|